View EO 12866 Meeting 0938-AT88

  Medicare Coverage of Innovative Technology (MCIT) and Definition of "Reasonable and Necessary" (CMS-3372)

  0938-HHS/CMS

  Proposed Rule Stage

  09/10/2021 01:00 PM

  AdvaMed   Kim Zimmerman

 
List of Documents
AdvaMed information and bios
 
List of Attendees Participation
•   Jennifer Friedman  - HHS Teleconference 
•   Scott Whitaker  - AdvaMed, CEO In Person 
•   Amanda Walsh  - AdvaMed In Person 
•   Mike Mussallem  - Edwards LifeSciences, Chairman and CEO In Person 
•   Kevin Conroy  - Exact Sciences, CEO and President In Person 
•   Carl St. Bernard  - CeloNova Biosciences, Inc., President and CEO In Person 
•   Nadim Yared  - CVRX, President and CEO In Person 
•   Peter Arduini  - Integra, President and CEO In Person 
•   Dr. Justin Klein  - Vensana Capital, Co-Founder and Managing Partner In Person 
•   Kim Zimmerman  - AdvaMed In Person 
•   Andrew Fish  - AdvaMed In Person 
•   Chandra Branham  - AdvaMed In Person 
•   Greg Crist  - AdvaMed In Person 
•   Julie Wise  - OMB Teleconference 
•   Elisabeth Daniel  - OMB/HD Teleconference 
•   Tiffany Swygert  - DPC Teleconference 
•   Rebecca Hirshorn  - HHS Teleconference